Prostatype Genomics AB (OSTO:PROGEN) Other Current Liabilities : kr2.14 Mil (As of Jun. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Prostatype Genomics AB Other Current Liabilities?

Prostatype Genomics AB's other current liabilities for the quarter that ended in Jun. 2023 was kr2.14 Mil.

Prostatype Genomics AB's quarterly other current liabilities increased from Dec. 2022 (kr1.51 Mil) to Mar. 2023 (kr1.81 Mil) and increased from Mar. 2023 (kr1.81 Mil) to Jun. 2023 (kr2.14 Mil).

Prostatype Genomics AB's annual other current liabilities declined from Dec. 2021 (kr1.68 Mil) to Dec. 2022 (kr1.51 Mil) but then increased from Dec. 2022 (kr1.51 Mil) to Dec. 2023 (kr2.99 Mil).

Prostatype Genomics AB Other Current Liabilities Historical Data

The historical data trend for Prostatype Genomics AB's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prostatype Genomics AB Other Current Liabilities Chart

Prostatype Genomics AB Annual Data

Trend

Jun18

Jun19

Dec21

Dec22

Dec23

Other Current Liabilities

Prostatype Genomics AB Quarterly Data
	Jun18	Jun19	Mar20	Jun20	Sep20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23
Other Current Liabilities	Get a 7-Day Free Trial											-	-	-	-	-

Prostatype Genomics AB Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Prostatype Genomics AB Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Prostatype Genomics AB's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Prostatype Genomics AB (OSTO:PROGEN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Prostatype Genomics AB (OSTO:PROGEN) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

PGO:Germany

Address

Gustaf III:s Boulevard 34, Solna, SWE, 169 73

Website

https://www.prostatypegenomics.com

Prostatype Genomics AB manufactures, markets and sells the prognostic gene test Prostatype. By assessing the aggressiveness of prostate cancer, Prostatype helps clinicians and patients to make correct treatment decisions. Over and under treatment of prostate cancer can be minimized, the quality of life for the patient improved and money can be saved for the health care sector.

Prostatype Genomics AB (OSTO:PROGEN) Headlines

No Headlines